what a joke
FDA clarifies the line between wellness and regulated medical devices
By Brian Dolan
January 16, 2015
funds going to sell off clovis and buy azn
AstraZeneca has previously said it believes Tagrisso could generate peak sales of $3 billion a year, making it a key product in the group's growing oncology portfolio.
too scared to hold overnight
farvardeen88 - Learn to find SEC forms. Sorry your short.
thanks- how much does it cost to get that news feed?
The camera maker was upgraded to "overweight" from "neutral" by analysts at Piper Jaffray.
The firm set its price target at $55,
Business Wire 4/8/15
CyberArk Announces Release Date of First Quarter 2015 Financial Results
CyberArk Software Ltd. (CYBR), the company that protects organizations from cyber attacks that have made their way inside the network perimeter, today announced that it will report its first quarter 2015 financial results after the U.S. financial markets close on Thursday, May 7, 2015.